Quality and innovation in supporting cancer care

Oncology has been a key focus and cornerstone of medac's success story throughout our corporate history. We have a strong track record of decades of reliable supply of medicinal products and supportive therapeutics across a wide range of diverse oncological indications. In addition to exceptional manufacturing capabilities, medac has many years of experience in market access, distribution, and sales.
Quality and innovation in supporting cancer care

Broad range of oncology products

From new drug formulations to targeted therapies, every pharmaceutical innovation at medac is based on our commitment to efficacy, safety, and to improving the overall quality of life for people facing a cancer diagnosis. We are proud to contribute time and time again to the advancement of treatment options available to oncologists and their patients. Today, we cover a broad range of first-, second- and third-line therapies for a variety of oncological indications.

Highest standards in products and services

At medac, we have a portfolio of numerous therapies that address the very diverse range of patients' needs in oncology. All medac products are manufactured in compliance with European quality standards, with proven safety and efficacy. Although some of the products themselves have been around for a long time, there is constant innovation in support services and adherence initiatives.

Our Focus Areas


Key rheumatological treatment improved

Rheumatic diseases imply a range of chronic treatment needs across a broad spectrum of patients. With the optimisation of a key treatment in this area, medac has succeeded in bringing a significant improvement to patients' quality of life.


Addressing unmet needs with urological therapies

Urology is a focus area of highest importance for medac. We have been active in this field from almost the very beginning of our company and are focused on developing a range of proprietary products that address a variety of unmet therapeutic needs.


Innovative and life-saving treatment options

Haematology is a focus area of high importance for medac. To find new treatment approaches for rare diseases, medac addresses critical needs in haematology and has developed innovative products to improve the outcomes of stem cell transplantation.

Reporting an adverse event

Apart from the desired effects, medical products can have side effects that are unpleasant or unintended. At medac, we continually collate information about side effects in order to monitor the benefit risk balance of each medication throughout its marketing lifecycle, and if necessary, can take action to better protect patient safety.

Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to medac Pharma at info@medacpharma.co.uk

We may contact you to gain further details about the report. However we are unable to provide medical advice. If you are concerned about any aspect of your treatment please discuss this with your healthcare professional (such as a doctor, nurse or pharmacist).



Please enter your email address and password to log in.